Carregant...
The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder
Although expanding the availability of buprenorphine—a first-line pharmacotherapy for opioid-use disorder (OUD)—has increased the capacity of healthcare systems to offer treatment, starting this medication is fraught with significant barriers. Standard induction regimens require persons with OUD to...
Guardat en:
| Publicat a: | Clin Drug Investig |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer International Publishing
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8020374/ https://ncbi.nlm.nih.gov/pubmed/33818748 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40261-021-01032-7 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|